Cencora, Inc. (COR) has 20 已知的内部人和机构持有人记录. 最大持有人为 Walgreens Boots Alliance Holdings LLC 持有 52,854,867 股. 其他重要持有人包括 Walgreens Boots Alliance, Inc. 和 STOLL ROGER G PHD.
过去12个月,内部人进行了 90 笔交易,涉及 COR 股票 — 34 笔买入 (价值为 $2.56M) 和 8 笔卖出 (价值为 $6.23M). 内部人买入超过卖出,可能表明对公司前景有信心.
COR 內部人持股
最大持股人
Walgreens Boots Alliance Holdings LLC
52,854,867 股
主要內部人持股
| # |
姓名 |
职位 |
持股数量 |
最近申报日期 |
相对规模 |
| 1 |
Walgreens Boots Alliance Holdings Llc |
Director |
52,854,867 |
2022-05-13 |
|
| 2 |
Walgreens Boots Alliance, Inc. |
10 Percent Owner |
19,980,000 |
2024-08-05 |
|
| 3 |
Stoll Roger G Phd |
Executive Chairman |
3,083,334 |
2012-08-14 |
|
| 4 |
Messinger Maria S |
Chief Financial Officer |
380,000 |
2009-08-24 |
|
| 5 |
Johnson Steven Andrew |
VP, Preclinical Development |
262,000 |
2009-08-24 |
|
| 6 |
Coleman James H |
Sr. VP, Business Development |
200,397 |
2007-11-19 |
|
| 7 |
Mansbach Harry H |
Chief Medical Officer |
100,000 |
2005-12-05 |
|
| 8 |
Chou John G. |
Executive Vice President |
81,367 |
2021-12-21 |
|
| 9 |
Mauch Robert P. |
President & CEO |
65,393 |
2026-02-20 |
|
| 10 |
Collis Steven H |
Executive Chairman |
58,699 |
2025-09-18 |
|
| 11 |
Breuil Robert S |
Chief Financial Officer |
50,000 |
2015-12-10 |
|
| 12 |
Tran Pierre V |
Chief Medical Officer |
50,000 |
2009-08-24 |
|
| 13 |
Singh Parminder |
CTO & Vice President, R&d |
45,000 |
2015-12-10 |
|
| 14 |
Rockwood Robert K. |
SVP, General Management |
39,868 |
2014-04-10 |
|
| 15 |
Drake Peter F |
Director |
30,000 |
2012-08-07 |
|
| 16 |
Allnutt Robert |
Director |
30,000 |
2012-08-07 |
|
| 17 |
Casamento Charles J |
Director |
30,000 |
2010-03-04 |
|
| 18 |
Cotman Carl W |
Director |
30,000 |
2012-08-07 |
|
| 19 |
Gochnauer Richard W |
Director |
28,762 |
2024-03-13 |
|
| 20 |
Staple Peter D |
President & CEO |
28,378 |
2016-05-17 |
|
近期交易 (过去12个月)
| 日期 |
姓名 |
职位 |
类型 |
股数 |
股价 |
总价值 |
| 2026-04-01 |
Krikorian Lazarus |
SVP & Chief Accounting Officer |
限制性股票授予 (RSU) |
3,936 |
- |
- |
| 2026-03-11 |
Campbell Elizabeth S |
Executive Vice President |
期权行权(卖出) |
12,623 |
- |
- |
| 2026-03-11 |
Battaglia Silvana |
Executive Vice President |
期权行权(卖出) |
8,415 |
- |
- |
| 2026-03-11 |
Cleary James F |
Chief Financial Officer |
期权行权(卖出) |
12,623 |
- |
- |
| 2026-03-05 |
Baumann Werner |
Director |
限制性股票授予 (RSU) |
557 |
$359.28 |
$200.12K |
| 2026-03-05 |
Miller Redonda |
Director |
限制性股票授予 (RSU) |
557 |
$359.28 |
$200.12K |
| 2026-03-05 |
Tyler Lauren M |
Director |
限制性股票授予 (RSU) |
557 |
$359.28 |
$200.12K |
| 2026-01-30 |
Tyler Lauren M |
Director |
限制性股票授予 (RSU) |
84 |
$359.22 |
$30.17K |
| 2026-03-05 |
Clyburn Frank |
Director |
限制性股票授予 (RSU) |
557 |
$359.28 |
$200.12K |
| 2026-03-05 |
Nally Dennis M |
Director |
限制性股票授予 (RSU) |
557 |
$359.28 |
$200.12K |
| 2026-01-30 |
Nally Dennis M |
Director |
限制性股票授予 (RSU) |
98 |
$359.22 |
$35.2K |
| 2026-03-05 |
Kim Lorence H. |
Director |
限制性股票授予 (RSU) |
557 |
$359.28 |
$200.12K |
| 2026-03-05 |
Cooper Ellen |
Director |
限制性股票授予 (RSU) |
557 |
$359.28 |
$200.12K |
| 2026-01-30 |
Cooper Ellen |
Director |
限制性股票授予 (RSU) |
69 |
$359.22 |
$24.79K |
| 2026-03-05 |
Ryerkerk Lori |
Director |
限制性股票授予 (RSU) |
557 |
$359.28 |
$200.12K |
| 2026-03-05 |
Greenberg Lon R |
Director |
限制性股票授予 (RSU) |
557 |
$359.28 |
$200.12K |
| 2026-03-05 |
Durcan Dermot Mark |
Director |
限制性股票授予 (RSU) |
905 |
$359.28 |
$325.15K |
| 2026-02-20 |
Mauch Robert P. |
President & CEO |
期权行权(卖出) |
3,762 |
$86.09 |
$323.87K |
| 2026-02-18 |
Mauch Robert P. |
President & CEO |
知情卖出 |
1,333 |
$359.46 |
$479.16K |
| 2026-01-20 |
Cooper Ellen |
Director |
未知 |
- |
- |
- |
| 2026-01-20 |
Mauch Robert P. |
President & CEO |
期权行权(卖出) |
3,763 |
$86.09 |
$323.96K |
| 2025-09-30 |
Clyburn Frank |
Director |
未知 |
- |
- |
- |
| 2025-12-31 |
Campbell Elizabeth S |
Executive Vice President |
限制性股票授予 (RSU) |
34 |
$287.09 |
$9.76K |
| 2025-12-31 |
Battaglia Silvana |
Executive Vice President |
限制性股票授予 (RSU) |
27 |
$287.09 |
$7.75K |
| 2025-12-19 |
Campbell Elizabeth S |
Executive Vice President |
知情卖出 |
3,351 |
$342.10 |
$1.15M |